Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non–small cell lung cancer
William G. Breen(Mayo Clinic in Arizona), Christopher L. Hallemeier(Mayo Clinic in Arizona), Aaron S. Mansfield(Mayo Clinic), Kenneth W. Merrell(Mayo Clinic), Yolanda I. Garces(Mayo Clinic), Sean S. Park(Mayo Clinic), Kenneth R. Olivier(Mayo Clinic), Dennis A. Wigle(Mayo Clinic)
Cited by 2
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k